Simultaneous defeat of MCF7 and MDA-MB-231 resistances by a hypericin PDT–tamoxifen hybrid therapy

Currently the greatest challenge in oncology is the lack of homogeneity of the lesions where different cell components respond differently to treatment. There is growing consensus that monotherapies are insufficient to eradicate the disease and there is an unmet need for more potent combinatorial tr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:NPJ Breast Cancer
Main Authors: Theodossiou, Theodossis A., Ali, Muhammad, Grigalavicius, Mantas, Grallert, Beata, Dillard, Pierre, Schink, Kay Oliver, Olsen, Cathrine E., Wälchli, Sébastien, Inderberg, Else Marit, Kubin, Andreas, Peng, Qian, Berg, Kristian
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6458138/
https://ncbi.nlm.nih.gov/pubmed/30993194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-019-0108-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados